![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1312266 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of EPHA1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of EPHA1 mRNA | CTD | PMID:12154049 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1312266 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EPHA1 mRNA | CTD | PMID:19770486 | 2-acetamidofluorene | increases expression | ISO | RGD:1312266 | 6480464 | 2-Acetylaminofluorene results in increased expression of EPHA1 mRNA | CTD | PMID:17317680 | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of EPHA1 mRNA | CTD | PMID:30851411 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:1312266 | 6480464 | 4, 4'-diaminodiphenylmethane results in decreased expression of EPHA1 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1312266 | 6480464 | bis4-hydroxyphenylsulfone results in increased expression of EPHA1 mRNA | CTD | PMID:30951980 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1312266 | 6480464 | Fenretinide results in increased expression of EPHA1 mRNA | CTD | PMID:28973697 | 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | Decitabine results in increased expression of EPHA1 mRNA, Decitabine results in increased expression of EPHA1 protein | CTD | PMID:19277044 | 5-aza-2'-deoxycytidine | decreases methylation | EXP | | 6480464 | Decitabine results in decreased methylation of EPHA1 promoter | CTD | PMID:19277044 | afimoxifene | increases expression | EXP | | 6480464 | afimoxifene results in increased expression of EPHA1 mRNA | CTD | PMID:12154049 | aflatoxin B1 | multiple interactions | ISO | RGD:1304680 | 6480464 | Aflatoxin B1 results in decreased expression of and results in decreased activity of EPHA1 protein, Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of and results in decreased activity of EPHA1 protein] | CTD | PMID:25154877 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of EPHA1 exon | CTD | PMID:30157460 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of EPHA1 mRNA | CTD | PMID:21641981 more ... | aflatoxin B2 | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of EPHA1 exon | CTD | PMID:30157460 | amphetamine | increases expression | ISO | RGD:1304680 | 6480464 | Amphetamine results in increased expression of EPHA1 mRNA | CTD | PMID:30779732 | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of EPHA1 gene | CTD | PMID:25304211 | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EPHA1 mRNA | CTD | PMID:32525701 | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of EPHA1 gene | CTD | PMID:25304211 | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EPHA1 mRNA | CTD | PMID:32525701 | atrazine | multiple interactions | EXP | | 6480464 | [Atrazine co-treated with Arsenates] results in increased expression of EPHA1 mRNA | CTD | PMID:18585445 | belinostat | increases expression | EXP | | 6480464 | belinostat results in increased expression of EPHA1 mRNA | CTD | PMID:26272509 | belinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of EPHA1 mRNA | CTD | PMID:27188386 | benzo[a]pyrene | decreases expression | ISO | RGD:1312266 | 6480464 | Benzoapyrene results in decreased expression of EPHA1 mRNA | CTD | PMID:19770486, PMID:22228805 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzoapyrene results in decreased expression of EPHA1 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzoapyrene results in decreased methylation of EPHA1 exon | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzoapyrene affects the methylation of EPHA1 exon | CTD | PMID:30157460 | benzo[a]pyrene | multiple interactions | ISO | RGD:1312266 | 6480464 | [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA | CTD | PMID:27858113 | benzo[b]fluoranthene | multiple interactions | ISO | RGD:1312266 | 6480464 | [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA | CTD | PMID:27858113 | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzoepyrene results in increased methylation of EPHA1 exon | CTD | PMID:30157460 | benzopyran | multiple interactions | ISO | RGD:1304680 | 6480464 | Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of and results in decreased activity of EPHA1 protein], Benzopyrans results in increased expression of and results in increased activity of EPHA1 protein | CTD | PMID:25154877 | bisphenol A | decreases expression | ISO | RGD:1304680 | 6480464 | bisphenol A results in decreased expression of EPHA1 mRNA | CTD | PMID:25181051 | bisphenol A | increases methylation | ISO | RGD:1304680 | 6480464 | bisphenol A results in increased methylation of EPHA1 gene | CTD | PMID:28505145 | bisphenol F | increases expression | ISO | RGD:1312266 | 6480464 | bisphenol F results in increased expression of EPHA1 mRNA | CTD | PMID:30951980 | bortezomib | decreases expression | EXP | | 6480464 | Bortezomib results in decreased expression of EPHA1 mRNA | CTD | PMID:20977926 | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of EPHA1 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of EPHA1 mRNA | CTD | PMID:21592394 | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of EPHA1 mRNA | CTD | PMID:25979313 | carbon nanotube | decreases expression | ISO | RGD:1312266 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chrysene | multiple interactions | ISO | RGD:1312266 | 6480464 | [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA | CTD | PMID:27858113 | ciguatoxin CTX1B | affects expression | ISO | RGD:1312266 | 6480464 | Ciguatoxins affects the expression of EPHA1 mRNA | CTD | PMID:18353800 | clofibrate | decreases expression | ISO | RGD:1312266 | 6480464 | Clofibrate results in decreased expression of EPHA1 mRNA | CTD | PMID:23811191 | cocaine | affects expression | ISO | RGD:1304680 | 6480464 | Cocaine affects the expression of EPHA1 mRNA | CTD | PMID:15691709 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of EPHA1 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of EPHA1 mRNA | CTD | PMID:25562108 | daidzein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA | CTD | PMID:16963248 | dioxygen | multiple interactions | ISO | RGD:1312266 | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EPHA1 mRNA | CTD | PMID:30529165 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | ISO | RGD:1304680 | 6480464 | Endosulfan results in decreased expression of EPHA1 mRNA | CTD | PMID:29391264 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of EPHA1 mRNA | CTD | PMID:27188386 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of EPHA1 mRNA | CTD | PMID:26272509 | fulvestrant | increases expression | EXP | | 6480464 | fulvestrant results in increased expression of EPHA1 mRNA | CTD | PMID:12154049 | genistein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA | CTD | PMID:16963248 | glycitein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA | CTD | PMID:16963248 | gold atom | multiple interactions | ISO | RGD:1312266 | 6480464 | [Gold co-treated with Polyethylene Glycols] results in increased expression of EPHA1 mRNA | CTD | PMID:19695318 | gold(0) | multiple interactions | ISO | RGD:1312266 | 6480464 | [Gold co-treated with Polyethylene Glycols] results in increased expression of EPHA1 mRNA | CTD | PMID:19695318 | indole-3-methanol | affects expression | ISO | RGD:1304680 | 6480464 | indole-3-carbinol affects the expression of EPHA1 mRNA | CTD | PMID:21396975 | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of EPHA1 exon | CTD | PMID:30157460 | Monobutylphthalate | affects expression | ISO | RGD:1312266 | 6480464 | monobutyl phthalate affects the expression of EPHA1 mRNA | CTD | PMID:19162170 | N-methyl-4-phenylpyridinium | affects expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium affects the expression of EPHA1 mRNA | CTD | PMID:12710931 | N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | EXP | | 6480464 | Methylnitronitrosoguanidine results in increased expression of EPHA1 mRNA | CTD | PMID:12634122 | panobinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of EPHA1 mRNA | CTD | PMID:27188386 | paracetamol | affects expression | ISO | RGD:1312266 | 6480464 | Acetaminophen affects the expression of EPHA1 mRNA | CTD | PMID:17562736 | perfluorononanoic acid | decreases expression | EXP | | 6480464 | perfluorononanoic acid results in decreased expression of EPHA1 mRNA | CTD | PMID:32588087 | pirinixic acid | multiple interactions | ISO | RGD:1312266 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of EPHA1 mRNA | CTD | PMID:19710929 | pirinixic acid | decreases expression | ISO | RGD:1312266 | 6480464 | pirinixic acid results in decreased expression of EPHA1 mRNA | CTD | PMID:18445702, PMID:23811191 | ponatinib | decreases activity | EXP | | 6480464 | ponatinib results in decreased activity of EPHA1 protein | CTD | PMID:19878872 | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:1312266 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of EPHA1 mRNA | CTD | PMID:28903501 | propiconazole | decreases expression | ISO | RGD:1312266 | 6480464 | propiconazole results in decreased expression of EPHA1 mRNA | CTD | PMID:21278054 | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of EPHA1 mRNA | CTD | PMID:30851411 | raloxifene | increases expression | EXP | | 6480464 | Raloxifene Hydrochloride results in increased expression of EPHA1 mRNA | CTD | PMID:12154049 | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EPHA1 mRNA | CTD | PMID:12154049 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | sodium arsenate | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EPHA1 mRNA | CTD | PMID:32525701 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of EPHA1 mRNA | CTD | PMID:12760830 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of EPHA1 mRNA | CTD | PMID:29301061 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of EPHA1 mRNA | CTD | PMID:31533062 | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of EPHA1 mRNA | CTD | PMID:21592394 | testosterone | increases expression | ISO | RGD:1312266 | 6480464 | Testosterone results in increased expression of EPHA1 mRNA | CTD | PMID:19693291 | testosterone | decreases expression | ISO | RGD:1312266 | 6480464 | Testosterone results in decreased expression of EPHA1 mRNA | CTD | PMID:19693291 | testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of EPHA1 mRNA | CTD | PMID:21592394 | tetraphene | increases expression | ISO | RGD:1312266 | 6480464 | benzaanthracene results in increased expression of EPHA1 mRNA | CTD | PMID:26377693 | tetraphene | multiple interactions | ISO | RGD:1312266 | 6480464 | [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA | CTD | PMID:27858113 | titanium dioxide | decreases expression | ISO | RGD:1312266 | 6480464 | titanium dioxide results in decreased expression of EPHA1 mRNA | CTD | PMID:29264374 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of EPHA1 mRNA | CTD | PMID:24935251 | tunicamycin | increases expression | ISO | RGD:1312266 | 6480464 | Tunicamycin results in increased expression of EPHA1 mRNA | CTD | PMID:17127020 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of EPHA1 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of EPHA1 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of EPHA1 mRNA | CTD | PMID:27188386 | vinclozolin | decreases expression | ISO | RGD:1304680 | 6480464 | vinclozolin results in decreased expression of EPHA1 mRNA | CTD | PMID:23034163 | |